| Sep 18 |
BioCardia Regains Full Compliance with Nasdaq Listing Requirements
|
| Sep 15 |
Wall Street Breakfast: The Week Ahead
|
| Sep 9 |
BioCardia Announces Closing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules
|
| Sep 4 |
Peering Into BioCardia's Recent Short Interest
|
| Aug 30 |
BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules
|
| Aug 30 |
Why MongoDB Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
|
| Aug 29 |
Dow Jumps Over 100 Points; Nvidia Earnings Top Views
|
| Aug 29 |
Why BioCardia (BCDA) Stock Is Up 95% Today
|
| Aug 29 |
BioCardia shares climb as it gets FDA clearance for its Morph DNA product family
|
| Aug 29 |
BioCardia Announces FDA Market Clearance of Morph® DNA™ Steerable Introducer Product Family
|
